Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55).
about
Structure of complement fragment C3b-factor H and implications for host protection by complement regulatorsInsights into complement convertase formation based on the structure of the factor B-cobra venom factor complexStructural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitorProduction of biologically active complement factor H in therapeutically useful quantitiesGain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.A molecular insight into complement evasion by the staphylococcal complement inhibitor protein familyHuman C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation.Allosteric inhibition of complement function by a staphylococcal immune evasion protein.Complement System Part I - Molecular Mechanisms of Activation and Regulation.Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease riskAccess to the complement factor B scissile bond is facilitated by association of factor B with C3b protein.Pancreatic ductal adenocarcinoma: a review of immunologic aspects.The immunobiology of Guillain-Barré syndromes.Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulationInsights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase.Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode.3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase.Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor BRational engineering of a minimized immune inhibitor with unique triple-targeting properties.Hijacking Complement Regulatory Proteins for Bacterial Immune Evasion.A common CD55 rs2564978 variant is associated with the susceptibility of non-small cell lung cancer.The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity.Investigating the structure of the factor B vWF-A domain/CD55 protein-protein complex using DEER spectroscopy: successes and pitfalls.Disease-linked mutations in factor H reveal pivotal role of cofactor activity in self-surface-selective regulation of complement activation.Complement factor H binds to denatured rather than to native pentameric C-reactive protein.Solution Structures of Complement C2 and Its C4 Complexes Propose Pathway-specific Mechanisms for Control and Activation of the Complement Proconvertases.The role of properdin in the assembly of the alternative pathway C3 convertases of complement.DAF in diabetic patients is subject to glycation/inactivation at its active site residues.An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.Complement System and Age-Related Macular Degeneration: Implications of Gene-Environment Interaction for Preventive and Personalized Medicine
P2860
Q24646723-2FF86EE2-D3F6-4389-8734-BF20A92B7A51Q27646432-33B82A7A-EBFD-4F49-8044-81ABF48F1BFDQ27655786-4F9C86BA-8D0E-4E3A-A98C-66026F78036CQ28300280-167F6178-976D-4B3D-AAC7-41B079AD7533Q33373674-2D6B6067-C6E2-485D-BE23-E4CB93ABED1CQ33896074-7E4DEEE3-A774-472F-B33B-306A0E445534Q34162206-75B687BE-2176-4586-B09A-EE7CB8E4FF95Q34200056-FA2BFD29-98E2-4505-AC61-5B82A8EFD1BFQ34481071-5AB781E7-B954-4BF4-973B-53BA405E3E4AQ35008396-D005FDF8-7DDD-4042-8A88-66CA39511CDCQ35372492-CC27CE5A-61C3-4FC9-8B41-53F1F1D40A15Q35870682-3693AB89-1ACC-47BC-A309-08594E2F86E0Q36164122-AB9A9622-475D-4453-8F86-65A1226E63FAQ36718519-D15FE658-B1FD-4750-9295-552BC4F3351EQ36778860-AAC8C0F7-84E9-4EB0-A0D1-106D0DC33DF3Q36906411-D35AEB76-E563-465A-A7D3-D777FB52C9A5Q37070537-A3986BF6-E81C-4306-8C67-1A6A0C0D50DEQ37132696-2B21D0A1-6657-4B2B-8D8B-7A67658A5C22Q37300691-5CCEB821-6E29-4E09-980D-986893D0B99FQ37516016-9EE91C8C-FC63-496B-A721-51929507E81CQ37701576-6388444D-4346-40A7-A9B0-FF2C2E3F9D5DQ39968584-99B8939C-75E7-42E8-BF3E-13714EE88774Q40682669-B097334A-DBF5-4F67-9839-E875C5B19D19Q41377869-B1B32B6D-886D-4A2E-94B5-14A8C180A9DFQ42043743-53AF1D58-DF90-4483-935A-B33E7F415D65Q42380135-DA06BA24-878A-47B5-B7F3-2F4768F7B887Q46814862-AF12AB37-3D33-4BDD-8902-DB80E22E5BC7Q47832785-89495502-22CC-4B93-B6A4-8A16AD383B92Q51730313-0415E2B7-B308-493E-A0DF-2147E8A6BBEAQ58702202-F6F5B9B4-29B1-41D3-AE48-CD1F81E1A0F2
P2860
Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Molecular dissection of intera ...... ay accelerating factor (CD55).
@en
Molecular dissection of intera ...... and decay accelerating factor
@nl
type
label
Molecular dissection of intera ...... ay accelerating factor (CD55).
@en
Molecular dissection of intera ...... and decay accelerating factor
@nl
prefLabel
Molecular dissection of intera ...... ay accelerating factor (CD55).
@en
Molecular dissection of intera ...... and decay accelerating factor
@nl
P2860
P50
P356
P1476
Molecular dissection of intera ...... cay accelerating factor (CD55)
@en
P2093
Claire L Harris
Richard A Smith
P2860
P304
P356
10.1074/JBC.M410179200
P407
P577
2004-11-09T00:00:00Z